Terms: = Brain cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4 AND Treatment
206 results:
1. Association of Clinical, Tumor, and treatment Characteristics With Seizure Control in Patients With
Bruno F; Pellerino A; Conti Nibali M; Pronello E; Cofano F; Rossi M; Levis M; Bertero L; Soffietti R; Cassoni P; Garbossa D; Bello L; Rudà R
Neurology; 2024 May; 102(10):e209352. PubMed ID: 38684041
[TBL] [Abstract] [Full Text] [Related]
2. Epigenetic MLH1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques.
Deycmar S; Johnson BJ; Ray K; Schaaf GW; Ryan DP; Cullin C; Dozier BL; Ferguson B; Bimber BN; Olson JD; Caudell DL; Whitlow CT; Solingapuram Sai KK; Romero EC; Villinger FJ; Burgos AG; Ainsworth HC; Miller LD; Hawkins GA; Chou JW; Gomes B; Hettich M; Ceppi M; Charo J; Cline JM
J Transl Med; 2024 Mar; 22(1):292. PubMed ID: 38504345
[TBL] [Abstract] [Full Text] [Related]
3. Glioblastoma Therapy: Past, Present and Future.
Obrador E; Moreno-Murciano P; Oriol-Caballo M; López-Blanch R; Pineda B; Gutiérrez-Arroyo JL; Loras A; Gonzalez-Bonet LG; Martinez-Cadenas C; Estrela JM; Marqués-Torrejón MÁ
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473776
[TBL] [Abstract] [Full Text] [Related]
4. cdkn2a promoter methylation enhances self-renewal of glioblastoma stem cells and confers resistance to carmustine.
Wang J; Xi YF; Zhao Q; Guo JH; Zhang Z; Zhang MB; Chang J; Wu YQ; Su W
Mol Biol Rep; 2024 Mar; 51(1):385. PubMed ID: 38438773
[TBL] [Abstract] [Full Text] [Related]
5. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
6. Characterization of a Preclinical In Vitro Model Derived from a SMARCA4-Mutated Sinonasal Teratocarcinosarcoma.
Lorenzo-Guerra SL; Codina-Martínez H; Suárez-Fernández L; Cabal VN; García-Marín R; Riobello C; Vivanco B; Blanco-Lorenzo V; Sánchez-Fernández P; López F; Llorente JL; Hermsen MA
Cells; 2023 Dec; 13(1):. PubMed ID: 38201285
[TBL] [Abstract] [Full Text] [Related]
7. Improved prognostic stratification of patients with isocitrate dehydrogenase-mutant astrocytoma.
Weller M; Felsberg J; Hentschel B; Gramatzki D; Kubon N; Wolter M; Reusche M; Roth P; Krex D; Herrlinger U; Westphal M; Tonn JC; Regli L; Maurage CA; von Deimling A; Pietsch T; Le Rhun E; Reifenberger G
Acta Neuropathol; 2024 Jan; 147(1):11. PubMed ID: 38183430
[TBL] [Abstract] [Full Text] [Related]
8. "De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade.
Hadad S; Gupta R; Oberheim Bush NA; Taylor JW; Villanueva-Meyer JE; Young JS; Wu J; Ravindranathan A; Zhang Y; Warrier G; McCoy L; Shai A; Pekmezci M; Perry A; Bollen AW; Phillips JJ; Braunstein SE; Raleigh DR; Theodosopoulos P; Aghi MK; Chang EF; Hervey-Jumper SL; Costello JF; de Groot J; Butowski NA; Clarke JL; Chang SM; Berger MS; Molinaro AM; Solomon DA
Acta Neuropathol; 2023 Dec; 147(1):3. PubMed ID: 38079020
[TBL] [Abstract] [Full Text] [Related]
9. The chemotherapeutic agent doxorubicin induces brain senescence, with modulation by APOE genotype.
Demby T; Gross PS; Mandelblatt J; Huang JK; Rebeck GW
Exp Neurol; 2024 Jan; 371():114609. PubMed ID: 37944881
[TBL] [Abstract] [Full Text] [Related]
10. Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting.
Rautajoki KJ; Jaatinen S; Hartewig A; Tiihonen AM; Annala M; Salonen I; Valkonen M; Simola V; Vuorinen EM; Kivinen A; Rauhala MJ; Nurminen R; Maass KK; Lahtela SL; Jukkola A; Yli-Harja O; Helén P; Pajtler KW; Ruusuvuori P; Haapasalo J; Zhang W; Haapasalo H; Nykter M
Acta Neuropathol Commun; 2023 Nov; 11(1):176. PubMed ID: 37932833
[TBL] [Abstract] [Full Text] [Related]
11. Cutaneous metastasis from cervical cancer to the scalp and trunk: a case report and review of the literature.
Dai Y; Zhang Y; Ke X; Liu Y; Zang C
J Med Case Rep; 2023 Oct; 17(1):435. PubMed ID: 37853494
[TBL] [Abstract] [Full Text] [Related]
12. Identifying predictors of glioma evolution from longitudinal sequencing.
Mu Q; Chai R; Pang B; Yang Y; Liu H; Zhao Z; Bao Z; Song D; Zhu Z; Yan M; Jiang B; Mo Z; Tang J; Sa JK; Cho HJ; Chang Y; Chan KHY; Loi DSC; Tam SST; Chan AKY; Wu AR; Liu Z; Poon WS; Ng HK; Chan DTM; Iavarone A; Nam DH; Jiang T; Wang J
Sci Transl Med; 2023 Oct; 15(716):eadh4181. PubMed ID: 37792958
[TBL] [Abstract] [Full Text] [Related]
13. Elimination of senescent cells by treatment with Navitoclax/ABT263 reverses whole brain irradiation-induced blood-brain barrier disruption in the mouse brain.
Gulej R; Nyúl-Tóth Á; Ahire C; DelFavero J; Balasubramanian P; Kiss T; Tarantini S; Benyo Z; Pacher P; Csik B; Yabluchanskiy A; Mukli P; Kuan-Celarier A; Krizbai IA; Campisi J; Sonntag WE; Csiszar A; Ungvari Z
Geroscience; 2023 Oct; 45(5):2983-3002. PubMed ID: 37642933
[TBL] [Abstract] [Full Text] [Related]
14. KDM2B-Rearranged Soft Tissue Sarcomas Expand the Concept of BCOR-Associated Sarcoma.
Motoi T; Hirata M; Kukita Y; Satomi K; Tamura H; Adachi S; Matsushita Y; Horiguchi SI; Hishima T; Ikegami M; Okuma T; Tao K; Arakawa A; Ogawa C; Matsuda K; Ichimura K; Nakamura H; Mori T; Yoshida A
Mod Pathol; 2023 Nov; 36(11):100317. PubMed ID: 37634866
[TBL] [Abstract] [Full Text] [Related]
15. Impact of Concurrent Genomic Alterations on Clinical Outcomes in Patients With ALK-Rearranged NSCLC.
Lara-Mejía L; Cardona AF; Mas L; Martin C; Samtani S; Corrales L; Cruz-Rico G; Remon J; Galvez-Nino M; Ruiz R; Rios-Garcia E; Tejada F; Lozano-Vazquez N; Rosell R; Arrieta O
J Thorac Oncol; 2024 Jan; 19(1):119-129. PubMed ID: 37572870
[TBL] [Abstract] [Full Text] [Related]
16. A novel MRI-based deep learning networks combined with attention mechanism for predicting cdkn2a/B homozygous deletion status in IDH-mutant astrocytoma.
Zhang L; Wang R; Gao J; Tang Y; Xu X; Kan Y; Cao X; Wen Z; Liu Z; Cui S; Li Y
Eur Radiol; 2024 Jan; 34(1):391-399. PubMed ID: 37553486
[TBL] [Abstract] [Full Text] [Related]
17. Genomic alterations associated with postoperative nodular leptomeningeal disease after resection of brain metastases.
Morshed RA; Cummins DD; Nguyen MP; Saggi S; Vasudevan HN; Braunstein SE; Goldschmidt E; Chang EF; McDermott MW; Berger MS; Theodosopoulos PV; Daras M; Hervey-Jumper SL; Aghi MK
J Neurosurg; 2024 Feb; 140(2):328-337. PubMed ID: 37548547
[TBL] [Abstract] [Full Text] [Related]
18. Construction and validation of a prognostic model for colon adenocarcinoma based on bile acid metabolism-related genes.
Luo Q; Zhou P; Chang S; Huang Z; Zeng X
Sci Rep; 2023 Aug; 13(1):12728. PubMed ID: 37543674
[TBL] [Abstract] [Full Text] [Related]
19. Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas.
Medina EJ; Zohdy YM; Porto E; Revuelta Barbero JM; Bray D; Maldonado J; Rodas A; Mayol M; Morales B; Neill S; Read W; Pradilla G; Ioachimescu A; Garzon-Muvdi T
Front Endocrinol (Lausanne); 2023; 14():1195792. PubMed ID: 37529607
[TBL] [Abstract] [Full Text] [Related]
20. A threshold for mitotic activity and post-surgical residual volume defines distinct prognostic groups for astrocytoma IDH-mutant.
Tran S; Thomas A; Aliouat I; Karachi C; Lozano F; Mokhtari K; Dehais C; Feuvret L; Carpentier C; Giry M; Doukani A; Lerond J; Marie Y; Sanson M; Idbaih A; Carpentier A; Hoang-Xuan K; Touat M; Capelle L; Bielle F
Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12928. PubMed ID: 37503540
[TBL] [Abstract] [Full Text] [Related]
[Next]
